For the second day in a row, international currency moves had a huge impact on the stock market. With the Japanese yen having broken above the 100 yen-per-dollar mark yesterday, the dollar continued its advance against Japan's currency again today, gaining another 1%. The news sent Japanese stocks soaring, commodities like gold and oil falling, and bond prices plunging. But for U.S. stock market investors, the news had a much less dramatic effect, with the Dow Jones Industrials (DJINDICES: ^DJI ) finishing with a gain of about 36 points, while the broader market posted slightly stronger gains.
Looking at the largest gainers in the Dow, two companies stood out for very different reasons. On one hand, UnitedHealth (NYSE: UNH ) rose about 1.4%. Despite having no substantial news to justify the gains, UnitedHealth has benefited from increasing clarity about the impact of Obamacare on its revenue and earnings going forward. Moreover, as the market has soared, UnitedHealth's relatively low earnings multiple of just 12 looks increasingly attractive, especially in comparison to much higher-priced consumer stocks and other more traditional defensive plays.
Hot Long Term Companies To Buy Right Now: Pinnacle Entertainment Inc.(PNK)
Pinnacle Entertainment, Inc. owns, develops, and operates casinos, and related hospitality and entertainment facilities in the United States. It operates casinos, such as L'Auberge du Lac in Lake Charles, Louisiana; River City Casino and Lumiere Place in St. Louis, Missouri; Boomtown New Orleans in New Orleans, Louisiana; Belterra Casino Resort in Vevay, Indiana; Boomtown Bossier City in Bossier City, Louisiana; and Boomtown Reno in Reno, Nevada. The company also operates River Downs racetrack in southeast Cincinnati, Ohio. As of May 26, 2011, it operated seven casinos and one racetrack. The company was formerly known as Hollywood Park, Inc. and changed its name to Pinnacle Entertainment, Inc. in February 2000. Pinnacle Entertainment, Inc. was founded in 1935 and is based in Las Vegas, Nevada.
Advisors' Opinion:- [By Dan Radovsky]
Pinnacle Entertainment (NYSE: PNK ) has reached an agreement in principle with the Bureau of Competition of the Federal Trade Commission that would allow the company to complete its proposed acquisition of Ameristar Casinos (NASDAQ: ASCA ) , Pinnacle announced today.
- [By Ben Levisohn]
Pinnacle Entertainment (PNK) has gained 56% this year; Las Vegas Sands (LVS) has climbed 38%. And Deutsche Bank has nice things to say about both today.
BloombergFirst Pinnacle. Deutsche Bank’s Carlo Santarelli ponders the stock’s big move and comes away still seeing value in its shares. He writes:
When we upgraded PNK in April, our thesis centered on the FCF strength of the combined entities [Pinnacle completed its acquisition of Ameristar Casinos on Aug. 14], a handful of favorable catalysts, easing regional gaming comps, & an inexpensive relative valuation. Given the shares’ sizeable move since then, we believe it is worth revisiting the investment case. Post the announcement of several asset sales and the closing of the transaction, we are adjusting our estimates, raising our PT to $30 from $24, and maintaining our bullish view at current levels given what we still believe to be an attractive free cash flow valuation, meaningful potential synergy realization beyond the $40 mm of announced benefits, and a free option on a lagging regional recovery.
Santarelli also revisited Las Vegas Sands and there too, he likes what he sees. He writes:
With…LVS at [a share price level] that have been challenging to break from over the last year plus, we believe this time is different and hence we see continued upward momentum…In the case of LVS, we see; 1) meaningful mass market strength continuing through year end, setting the stage for upward company and market estimate revisions for 2014, 2) continued cash flow appreciation and capital returns serving as downside protection and positive catalysts, and 3) continued shared gains, largely driven by table optimization and mass market strength, driving both estimates and sentiment.
He also likes Wynn Resorts (WYNN), despite its 34% gain.�Santarelli writes:
As for WYNN, we believe near-term estimates continue to take a back seat to capital return
Top 5 Japanese Companies To Own In Right Now: 1st Constitution Bancorp(NJ)
1st Constitution Bancorp operates as a bank holding company for 1st Constitution Bank that provides community banking services to corporations, individuals, partnerships, and other community organizations in the central and northeastern New Jersey area. It offers various deposit products, including noninterest bearing demand deposits, interest bearing demand deposits, savings deposits, and time deposits, as well as certificates of deposit, and money market and NOW accounts. The company also provides a range of loan products comprising commercial loans for working capital, business expansion, and the purchase of equipment and machinery; construction loans to real estate developers for the acquisition, development and construction of residential subdivisions; residential consumer loans; term loans; lines of credit; loans secured by equipment and receivables; second mortgage home improvement loans; home equity lines of credit; and non-residential consumer loans for automobile s, recreation vehicles, and boats, as well as secured and unsecured personal loans, and deposit account secured loans. It provides its services through a network of 14 branches. The company was founded in 1989 and is based in Cranbury, New Jersey.
Advisors' Opinion:- [By Mark Skousen]
And that brings me to Nidec (NJ). Based in Kyoto, Japan, Nidec manufactures small- to mid-size motors, fan motors, and pivot assemblies used in dozens of IT products, as well as home appliances, automobiles, office equipment, and industrial machinery.
- [By Monica Gerson]
Nidec (NYSE: NJ) shares climbed 2.75% to $20.17. The volume of Nidec shares traded was 506% higher than normal. Nidec's trailing-twelve-month revenue is $9.42 billion.
Top 5 Japanese Companies To Own In Right Now: Questcor Pharmaceuticals Inc.(QCOR)
Questcor Pharmaceuticals, Inc., a biopharmaceutical company, provides prescription drugs for the treatment of auto-immune diseases. The company?s primary product is H.P. Acthar Gel (repository corticotropin injection), an injectable drug for the treatment of acute exacerbations of multiple sclerosis; infantile spasms in infants and children under two years of age; nephrotic syndrome; and Lupus. Questcor Pharmaceuticals, Inc. was founded in 1990 and is headquartered in Anaheim, California.
Advisors' Opinion:- [By Luke Jacobi]
Questcor Pharmaceuticals (NASDAQ: QCOR) shot up 9.18 percent to $59.62 after the company lifted its quarterly dividend by 20%.
Shares of Citrix Systems (NASDAQ: CTXS) dropped 11.87 percent to $58.75 after the company lowered its forecast for the third quarter.
- [By Ben Levisohn]
Taser has dropped 4% this morning after gaining 33% during the past month. That gain would have put it in the top-ten in the S&P 1500 if it were a member of� the index, behind Questcor Pharmaceuticals (QCOR), which has gained 36%, healthcare company Amedisys (AMED) and Affymetrix (AFFX), which has gained 44%, among others.
- [By DailyFinance Staff]
Concerns about the political uncertainty in Ukraine caused some volatility in the markets Friday afternoon, with the major indexes making several U-turns ahead of the weekend. The Dow Jones industrial average (^DJI), which had been up by as much as 125 points, briefly dropped into loss territory before rebounding to end 49 points higher. The Standard & Poor's 500 index (^GPSC) edged up 5 points, adding to Thursday's record high, but the Nasdaq composite (^IXIC) lost 10 points. AP/Darko VojinovicPro-Russian militias have seized local government buildings in Crimea, Ukraine; the unrest there is making investors around the world nervous. February was a great month for investors. All three major averages jumped by about 4 percent. UnitedHealth Group (UNH) led the blue chips, gaining 1½ percent. Other health providers – Aetna (AET), Wellpoint (WLP), Cigna (CI) and Humana (HUM) -- all gained between 1½ and 2 percent. And retail stocks remained active. Target (TGT) added another 3 percent. Best Buy rose 4 percent, and Fred's (FRED), a regional department store chain, jumped 10 percent. But Pier 1 (PIR) fell 5½ percent after lowering its earnings outlook for a second time. That led to a series of brokerage downgrades. Decker Outdoor (DECK) tumbled 12 percent. The maker of footwear brands such as Ugg and Teva issued a weak outlook. And apparel maker Lululemon (LULU) fell 5-percent on negative comments from Credit Suisse. It seems as though there are always some big movers in the drug and biotech sectors – and that was certainly the case today. GW Pharmaceuticals (GWPH) rose 2 percent after the FDA granted orphan status to its drug to treat a rare form of childhood epilepsy. But most of the action was on the downside. Endologix (ELGX) slid 24 percent after forecasting lower revenue growth. Questcor (QCOR) fell 10 percent. It's lost big for three straight days amid allegations of questionable business practices. Jazz Pharma
Top 5 Japanese Companies To Own In Right Now: AcelRx Pharmaceuticals Inc.(ACRX)
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute and breakthrough pain in the United States. The company develops ARX-01, a Sufentanil NanoTab PCA system, which completed Phase II clinical trial for acute post-operative pain. The Sufentanil NanoTab PCA system consists of sufentanil, a high therapeutic index opioid; NanoTabs, a non-invasive sublingual dosage form; and a handheld PCA device that enables simple patient-controlled delivery of NanoTabs in the hospital setting and eliminates the risk of programming errors. Its products also include ARX-02, a Sufentanil NanoTab BTP Management System that completed Phase II clinical trial for the treatment of cancer breakthrough pain; and ARX-03, a Sufentanil/Triazolam NanoTab, which completed Phase II clinical trial to provide mild sedation, anxiety reduction, and pain relief for patients undergoing painful procedures in a ph ysician?s office. The company was formerly known as SuRx, Inc. and changed its name to AcelRx Pharmaceuticals, Inc. in August 2006. AcelRx Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Redwood, California.
Advisors' Opinion:- [By StockMatusow]
One company that had an offering received very well is AcelRx Pharmaceuticals (ACRX). AcelRx is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain. On July 19, 2013, AcelRx offered 570,000 shares priced at $11.65. Investors aggressively bought the offering and the stock now sits at $11.96 per share. We covered AcelRx this year when it was about $6.50 per share. It reached highs since of $13.50, which effectively makes it more than a double.
No comments:
Post a Comment